New inhaled COVID-19 vaccine by McMaster enters phase-2 trials in Canada. The vaccine aims to provide stronger, needle-free ...

Imagine if antibodies, hormones for fertility, proteins like insulin, and vaccines could be swallowed instead of taken by ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Donald Trump's health secretary vowed to “Make America Healthy Again" but has delivered an inconsistent message that has ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

New data announced by Vaxxas supports the use of its high-density microarray patch (HD-MAP) technology to deliver DNA-based ...

US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on ...

Abrupt staffing changes have also dominated Kennedy's first weeks in office, with CDC pick Dave Weldon, MD, withdrawing from ...